FILING ANALYSIS · THURSDAY, OCTOBER 29

Rafael Holdings, Inc. RFL — 8-K: Results of Operations and Financial Condition

neutral

The company's NDA submission for remibetadex is a significant development, but the Phase 3 study did not meet its primary endpoint, which may impact the stock's performance. The financial results show a decrease in net loss, largely due to a decrease in general and administrative expenses.

The filing

8-K - Rafael Holdings, Inc. (0001713863) (Filer)

Read the filing on SEC EDGAR →

How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.

Get filings like this every market day

The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.

Subscribe free →
All analyses · Earnings today · Latest brief · Track record
© 2026 Dutchcode B.V. · Built by
Blinkof.ai verified — grade A+